Jan 13, 2021
The previous episode has been very informative about the role of private equity in medical sales, especially when it comes to medical startups. As Samuel Gbadebo continues to talk with JAR Bio’s Carlos Gregory, they shift their conversation to discuss the game-changing product that his company is putting out to the market. JAR Bio is creating a positive impact on the COVID-19 management sphere with their innovative disinfection technology powered by Medisystem. Imagine a device that will let you walk out of a room, leave it for seven minutes and come back with it completely disinfected. That’s what the company actually offers! It is a simple yet elegant technology that has a lot of applications – from medicine to air travel and lots of industries in between. Listen in and learn more.